Precision Medicine

While traditional CAR-T therapies often focus on a single antigen, C-CAR039 utilizes a dual-targeting mechanism to reduce the likelihood of tumor escape in aggressive lymphoma cases. This specific design addresses one of the most significant challenges in cellular immunotherapy: the down-regulation

A woman’s geographic location within Sweden’s borders might currently play a more decisive role in her cancer recovery than the genetic mutations found within her tumor cells. Despite a reputation for providing world-class, egalitarian medical care, the Swedish healthcare system is grappling with

Advances in protein design and enzyme engineering now allow for the rapid modification of bioactive substances, such as decaffeinating beverages in minutes by mimicking the body’s natural metabolic pathways. This breakthrough represents a broader shift toward what Aryeh Ganz and Cornucopian Capital

Detecting minimal residual disease through high-sensitivity blood tests allows clinicians to identify high-risk patients who might benefit from immediate cellular therapy despite appearing to be in remission. This shift toward early intervention represents a departure from traditional

The discovery of genetic precursors to myelofibrosis offers a critical window of opportunity for clinicians to shift from reactive treatment models toward proactive, personalized surveillance strategies. For decades, the medical community has struggled with the silent progression of

By identifying relevant microscopic patterns across large image patches, new AI models can process the immense complexity of whole slide images much faster than manual human observation. Modern computational pathology is undergoing a radical transformation as deep learning architectures move beyond